Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 31% ± 13% | |
brain | 17 studies | 28% ± 12% | |
peripheral blood | 14 studies | 27% ± 8% | |
intestine | 10 studies | 25% ± 11% | |
eye | 9 studies | 26% ± 11% | |
kidney | 8 studies | 24% ± 5% | |
liver | 8 studies | 36% ± 20% | |
pancreas | 5 studies | 43% ± 22% | |
bone marrow | 5 studies | 25% ± 6% | |
uterus | 5 studies | 35% ± 16% | |
prostate | 5 studies | 28% ± 10% | |
heart | 4 studies | 21% ± 4% | |
lymph node | 4 studies | 30% ± 11% | |
breast | 4 studies | 32% ± 11% | |
adipose | 4 studies | 23% ± 6% | |
placenta | 3 studies | 37% ± 5% | |
thymus | 3 studies | 35% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 6562.66 | 180 / 180 | 100% | 69.76 | 430 / 430 |
pancreas | 100% | 7019.09 | 328 / 328 | 100% | 45.72 | 178 / 178 |
prostate | 100% | 11861.99 | 245 / 245 | 100% | 67.30 | 502 / 502 |
thymus | 100% | 8124.81 | 653 / 653 | 100% | 59.94 | 605 / 605 |
uterus | 100% | 8685.44 | 170 / 170 | 100% | 64.31 | 459 / 459 |
esophagus | 100% | 12446.88 | 1444 / 1445 | 100% | 103.03 | 183 / 183 |
brain | 100% | 8826.87 | 2638 / 2642 | 100% | 71.17 | 704 / 705 |
breast | 100% | 8251.49 | 459 / 459 | 100% | 92.34 | 1114 / 1118 |
liver | 100% | 5210.40 | 225 / 226 | 100% | 33.79 | 405 / 406 |
lung | 99% | 8064.35 | 575 / 578 | 100% | 73.32 | 1153 / 1155 |
skin | 100% | 10812.58 | 1808 / 1809 | 99% | 74.95 | 468 / 472 |
bladder | 100% | 12340.57 | 21 / 21 | 99% | 65.58 | 499 / 504 |
kidney | 100% | 7587.34 | 89 / 89 | 99% | 51.60 | 892 / 901 |
stomach | 100% | 8549.25 | 359 / 359 | 99% | 72.21 | 283 / 286 |
intestine | 100% | 10987.15 | 966 / 966 | 98% | 66.51 | 518 / 527 |
adrenal gland | 100% | 7548.10 | 258 / 258 | 98% | 37.64 | 226 / 230 |
adipose | 100% | 8824.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10140.38 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 64.06 | 29 / 29 |
muscle | 100% | 14948.10 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7764.72 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 70.38 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.00 | 1 / 1 |
heart | 99% | 12916.75 | 856 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 30.13 | 75 / 80 |
peripheral blood | 43% | 4645.26 | 404 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006446 | Biological process | regulation of translational initiation |
GO_0006413 | Biological process | translational initiation |
GO_0042255 | Biological process | ribosome assembly |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0005525 | Molecular function | GTP binding |
GO_0000049 | Molecular function | tRNA binding |
GO_0003924 | Molecular function | GTPase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | EIF5B |
Protein name | Eukaryotic translation initiation factor 5B (Translation initiation factor IF-2) Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2) eIF5B protein |
Synonyms | KIAA0741 IF2 |
Description | FUNCTION: Plays a role in translation initiation . Ribosome-dependent GTPase that promotes the joining of the 60S ribosomal subunit to the pre-initiation complex to form the 80S initiation complex with the initiator methionine-tRNA in the P-site base paired to the start codon . Together with eIF1A (EIF1AX), actively orients the initiator methionine-tRNA in a conformation that allows 60S ribosomal subunit joining to form the 80S initiation complex . Is released after formation of the 80S initiation complex . Its GTPase activity is not essential for ribosomal subunits joining, but GTP hydrolysis is needed for eIF1A (EIF1AX) ejection quickly followed by EIF5B release to form elongation-competent ribosomes . In contrast to its procaryotic homolog, does not promote recruitment of Met-rRNA to the small ribosomal subunit . . |
Accessions | Q8N5A0 ENST00000617677.1 A0A087WUT6 Q05CQ1 ENST00000289371.11 O60841 A0JLR8 |